Education
About Us
Working with TipRanks
Follow Us
Robin Washington Insider Profile
4 Followers
Robin Washington, EVP, CFO at Gilead Sciences, holds 43.45K shares in Salesforce (Ticker: CRM), holds 13.17K shares in Honeywell International (Ticker: HON), holds 30.33K shares in Alphabet Class C (Ticker: GOOG). Most recently, Robin Washington Bought ― shares of Salesforce on Mar 03, 2025 for an estimated value of 499.35K.
Profitable Transactions
4 out of 12 Profitable Transactions
Average Return
-11.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robin Washington holds in companies
Most Profitable Insider Trade
The most profitable trade made by Robin Washington
Robin Washington's Trading History
Gilead Sciences
Mar 14, 2019
EVP, CFO
Uninformative Buy
18.96K
$16.31M
Alphabet Class C
Dec 18, 2024
Director
Uninformative Buy
―
$5.33M
Alphabet Class A
Jul 05, 2019
Director
Uninformative Buy
―
$5.27M
Vertiv Holdings
Nov 21, 2024
Director
Uninformative Sell
673.48K
$425.20K
Catalyst Partners Acquisition
―
―
―
―
Salesforce
Mar 03, 2025
Director
Informative Buy
499.35K
$12.29M
Honeywell International
Feb 20, 2025
Director
Uninformative Buy
101.84K
$2.83M
Mips Technologies
―
―
―
―
List of latest transactions for each holding click on a transaction to see Robin Washington's performance on stock
You May Also Like
Robin Washington insider profile FAQ
What is the percentage of profitable transactions made by Robin Washington?
The percentage of profitable transactions made by Robin Washington is 33%.
What is the average return per transaction made by Robin Washington?
The average return per transaction made by Robin Washington is -11.60%.
What stocks does Robin Washington hold?
Robin Washington holds: GILD, GOOG, GOOGL, VRT, CPAR, CRM, HON, MIPS stocks.
What was Robin Washington’s latest transaction?
Robin Washington latest transaction was an Informative Buy of $499.35K.
What was Robin Washington's most profitable transaction?
Robin Washington’s most profitable transaction was an Informative Sell of GILD stock on May 5, 2015. The return on the trade was 15.20%.
What is Robin Washington's role in Gilead Sciences?
Robin Washington's role in Gilead Sciences is EVP, CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.